Watson DG - Search Results

1

Metabolism of isometamidium in hepatocytes isolated from control and inducer-treated rats.

Boibessot I, Tettey JN, Skellern GG, Watson DG, Grant MH. Boibessot I, et al. Among authors: watson dg. J Vet Pharmacol Ther. 2006 Dec;29(6):547-53. doi: 10.1111/j.1365-2885.2006.00802.x. J Vet Pharmacol Ther. 2006. PMID: 17083459

2

The analysis of thiocarbamides by gas chromatography/negative-ion chemical-ionization mass spectrometry.

Watson DG, Bates CD, Skellern GG, Mairs R, Martin S. Watson DG, et al. Rapid Commun Mass Spectrom. 1991 Mar;5(3):141-2. doi: 10.1002/rcm.1290050311. Rapid Commun Mass Spectrom. 1991. PMID: 1804411

3

Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine.

Mairs RJ, Gaze MN, Watson DG, Skellern GG, Constable P, McKellar K, Owens J, Vaidyanathan G, Zalutsky MR. Mairs RJ, et al. Among authors: watson dg. Nucl Med Commun. 1994 Apr;15(4):268-74. doi: 10.1097/00006231-199404000-00157. Nucl Med Commun. 1994. PMID: 8072739

4

Comparative study of the determination of bupivacaine in human plasma by gas chromatography-mass spectrometry and high-performance liquid chromatography.

Tahraoui A, Watson DG, Skellern GG, Hudson SA, Petrie P, Faccenda K. Tahraoui A, et al. Among authors: watson dg. J Pharm Biomed Anal. 1996 Nov;15(2):251-7. doi: 10.1016/0731-7085(96)01774-8. J Pharm Biomed Anal. 1996. PMID: 8933427

5

LC determination of octreotide acetate in compound formulations of Sandostatin and diamorphine hydrochloride.

Kyaterekera N, Tettey JN, Skellern GG, Watson DG, Urie J, McDade JR, Fielding H. Kyaterekera N, et al. Among authors: watson dg. J Pharm Biomed Anal. 1999 Nov;21(2):327-30. doi: 10.1016/s0731-7085(99)00123-5. J Pharm Biomed Anal. 1999. PMID: 10703987

6

The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes.

Fielding H, Kyaterekera N, Skellern GG, Tettey JN, McDade JR, Msuya Z, Watson DG, Urie J. Fielding H, et al. Among authors: watson dg. Palliat Med. 2000 May;14(3):205-7. doi: 10.1191/026921600666997498. Palliat Med. 2000. PMID: 10858828

7

Isolation and identification of three potential impurities of pholcodine bulk drug substance.

Denk OM, Gray AI, Skellern GG, Watson DG. Denk OM, et al. Among authors: watson dg. J Pharm Pharmacol. 2000 Jul;52(7):819-29. doi: 10.1211/0022357001774679. J Pharm Pharmacol. 2000. PMID: 10933132

8

Micellar electrokinetic and high-performance liquid chromatographic determination of potential manufacturing impurities in pholcodine.

Denk OM, Watson DG, Skellern GG. Denk OM, et al. Among authors: watson dg. J Chromatogr A. 2000 Oct 20;895(1-2):9-16. doi: 10.1016/s0021-9673(00)00526-4. J Chromatogr A. 2000. PMID: 11105843

9

Chiral analysis of methylphenidate and dextromoramide by capillary electrophoresis.

Denk OM, Watson DG, Skellern GG. Denk OM, et al. Among authors: watson dg. J Chromatogr B Biomed Sci Appl. 2001 Sep 15;761(1):61-8. doi: 10.1016/s0378-4347(01)00300-0. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11585132

10

Impurity profiling of pholcodine by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS).

Denk OM, Skellern GG, Watson DG. Denk OM, et al. Among authors: watson dg. J Pharm Pharmacol. 2002 Jan;54(1):87-98. doi: 10.1211/0022357021771788. J Pharm Pharmacol. 2002. PMID: 11829134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters